Skip to main content
. Author manuscript; available in PMC: 2009 Dec 1.
Published in final edited form as: J Hypertens. 2008 Dec;26(12):2414–2425. doi: 10.1097/HJH.0b013e328312c86a

Fig. 1.

Fig. 1

Chemical structures of bufadienolide (a) and cardenolide (b) CTS. Displacement of binding of 3E9 (c) and 4G4 (d) anti-MBG mAbs to MBG–thyroglobulin conjugates by MBG (○), cinobufotalin (●), bufalin (▲), cinobufagin (△), ouabain (■), and digoxin (□) in DELFIA competitive fluoroimmunoassay. CTS, cardiotonic steroids; DELFIA, dissociation-enhanced fluoroimmunoassay; mAb, monoclonal anti-marinobufagenin antibody; MBG, marinobufagenin.